Rinascera Therapeutics, Inc.
CIK 2090779 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Rinascera Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 8, 2025 | D | 0002090779-25-000001 |